Allain H , Le Coz F , Borderies P , Schuck S , de la Giclais B , Patat A , Gandon J M (1998) Use of zolpidem as a benzodiazepine substitute in 84 patients with insomnia . Hum Psychopharmacol13: 551-559
2.
Benca R M (2001) Consequences of insomnia and its therapies . J Clin Psychiatry62(Suppl 10): 33-38
3.
Cluydts R , Peeters K , de Bouyalsky I , Lavoisy J (1998) Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study . J Int Med Res26: 13-24
4.
Drake C L , Roehrs T , Roth R (2003) Insomnia causes, consequences, and therapeutics: an overview . Depress Anxiety18: 163-176
5.
Hajak G , Cluydts R , Declerck A , Estivill S E , Middleton A , Sonka K , Unden M (2002) Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale double-blind, randomized, outpatient study . Int J Clin Psychopharmacol17: 9-17
6.
Hajak G , Muller W E , Wittchen H U , Pittrow D , Kirsch W (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data . Addiction98: 1371-1378
7.
Hindmarch I , Patat A , Stanley N , Paty I , Rigney U (2001) Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening . Hum Psychopharmacol16: 159-167
8.
Holm K J , Goa K L (2000) Zolpidem . Drugs59: 865-889
9.
Hurst M , Noble S (1999) Zaleplon . CNS drugs11: 387-392
10.
Lader M (1998) Withdrawal problems after stopping hypnotics in patients with insomnia . CNS Drugs10: 425-440
11.
Ohayon M M , Caulet M , Priest R G , Guilleminault C (1998) Psychotropic medication consumption patterns in the UK general population . J Clin Epidemiol51: 273-283
12.
Ohayon M M , Lader M H (2002) Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom . J Clin Psychiatry63: 817-825
13.
Soldatos C R , Dikeos D G , Whitehead A (1999) Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies . Int Clin Psychopharmacol14: 287-303
14.
Ustun T B , Privett M , Lecrubier Y , Weiller E , Simon G , Korten A , Bassett S S , Maier W , Sartorius N (1996) Form, frequency and burden of sleep problems in general health care . Eur Psychiatry11(Suppl 1): 5S-10S
15.
Vermeeren A (2004) Residual effects of hypnotics. Epidemiology and clinical implications . CNS Drugs18: 297-328
16.
Vermeeren A , Danjou P E , O’Hanlon J F (1998) Residual effects of evening and middle-of-the night administration of zaleplon 10 and 20 mg on memory and actual driving performance . Hum Psychopharmacol13: S98-S107
17.
Walsh J K , Pollak C P , Scharf M B , Schweitzer P K , Vogel G W (2000) Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia . Clin Neuropharmacol23: 17-21
